ASPH and hepatocellular carcinoma: We have demonstrated that a λ phage vaccine construct expressing a N-terminal peptide of ASPH when combined with a checkpoint inhibitor substantially reduces both primary tumor growth and multi-organ metastasis in murine models of TNBC and HCC.